Epidemiology, clinical manifestations, and molecular typing of salmonella typhi isolated from patients with typhoid fever in Lebanon  by Kanj, Souha S. et al.
Journal of Epidemiology and Global Health (2015) 5, 159–165http : / / www.elsev ier .com/ locateEpidemiology, clinical manifestations,
and molecular typing of salmonella typhi
isolated from patients with typhoid fever
in Lebanonhttp://dx.doi.org/10.1016/j.jegh.2014.07.003
2210-6006/ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
* Corresponding author at: Department of Internal Medicine,
Division of Infectious Diseases, American University of Beirut
Medical Center, PO Box 11-0236 Cairo Street, Riad El Solh 1107
2020, Beirut, Lebanon. Tel.: +961 1350000x5381; fax: +961 1
370814.
E-mail address: sk11@aub.edu.lb (S.S. Kanj).
1 Both authors contributed equally to the manuscript./ jeghSouha S. Kanj a,b,*, Zeina A. Kanafani a,b, Marwa Shehab b,c,1,
Nisreen Sidani a,1, Tania Baban a,b, Kedak Baltajian a,
Ghenwa K. Dakdouki d, Mohamad Zaatari d, George F. Araj b,e,
Rima Hanna Wakim b,f, Ghassan Dbaibo b,f, Ghassan M. Matar b,ca Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
b Center for Infectious Diseases Research, American University of Beirut Medical Center, Beirut, Lebanon
c Department of Experimental Pathology, Microbiology and Immunology, American University of Beirut
Medical Center, Beirut, Lebanon
d Hammoud Hospital University Medical Center, Sidon, Lebanon
e Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center,
Beirut, Lebanon
f Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center,
Beirut, LebanonReceived 5 November 2013; received in revised form 13 July 2014; accepted 17 July 2014
Available online 10 September 2014KEYWORDS
Salmonella typhi;
Typhoid fever;
Enteric fever;
Food borne diseases;
Molecular typing;
Middle eastAbstract The objective of this study was to examine the epidemiology and the
clinical manifestations of typhoid fever as well as the susceptibility and strain relat-
edness of Salmonella typhi isolates in Lebanon from 2006 to 2007. A total of 120
patients with typhoid fever were initially identified from various areas of the coun-
try based on positive culture results for S. typhi from blood, urine, stools, bone mar-
row and/or positive serology. Clinical, microbiological and molecular analysis was
performed on cases with complete data available. These results indicated that
160 S.S. Kanj et al.drinking water was an unlikely mode of transmission of the infection. Despite
increasing reports of antimicrobial resistance among S. typhi isolates, the vast
majority of these isolates were susceptible to various antibiotic agents, including
ampicillin, cephalosporins, quinolones, and trimethoprim/sulfamethoxazole. Molec-
ular analysis of the isolates revealed a predominance of one single genotype with no
variation in distribution across the geographical regions.
ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Typhoid fever is a systemic infection caused by the
enteric gram-negative bacterium Salmonella
enterica serovar typhi (S. typhi) [1,2]. This food
and waterborne disease is strongly correlated with
poor hygiene as well as overpopulated areas with
poor sanitation [1,3]. Typhoid fever continues to
be a serious global public health problem and is a
major cause of morbidity and mortality in the
developing world. High areas of endemicity include
South-central Asia, Southeast Asia, and Southern
Africa.
According to the World Health Organization, it is
estimated that the yearly incidence of typhoid
fever exceeds 21 million cases with over 200,000
deaths [4]. In the United States, 200–300 new
cases are reported annually, most of which occur
in travelers returning from endemic countries [5].
Epidemiological methods to determine clonal
relatedness have been increasingly used in various
settings. Pulsed-field gel electrophoresis (PFGE) is
a well-established and highly effective epidemio-
logical tool for the molecular analysis of large frag-
ments generated by restriction endonuclease
digestion of genomic DNA. It is used to subtype S.
typhi for surveillance purposes, to identify and
investigate outbreaks, as well as to characterize
endemic strains. The use of PFGE with endonucle-
ase XbaI is now widely recognized as a sensitive
means of fingerprinting Salmonella serovars, and
it has recently become a reference method [6].
Although historically initiated in 1957, surveil-
lance for communicable diseases in Lebanon was
interrupted during the civil war from 1975 to
1994 and was only re-initiated in 1995 [7]. The local
epidemiology of typhoid fever has not been well
established, hence the rationale behind this study.
The objective was to describe the clinical manifes-
tations and risk factors for typhoid fever in this
patient population. Antimicrobial susceptibility
and molecular analysis to determine the strain
relatedness of the collected S. typhi isolates were
also performed, and the results were correlated
with the clinical data.2. Methods
2.1. Identification of subjects and data
collection
This was an observational study conducted at 14
hospitals in Lebanon. Cases of typhoid fever were
identified between October 2006 and January
2008 based on positive culture results for S. typhi
from blood, urine, stools, bone marrow and/or
positive serology obtained from microbiology labo-
ratories. Only one culture per patient was
included. Patient-specific clinical and laboratory
data were collected retrospectively from patients
medical records. Information was collected on
patient demographics, area of residence, source
of water supply, socioeconomic status and living
conditions, clinical signs and symptoms upon pre-
sentation, and laboratory, radiological and patho-
logic findings, in addition to the treatment
regimen and final outcome. Data entry and statisti-
cal analysis were performed using SPSS 19.0 for
Windows (SPSS Inc., Chicago, IL, USA). Because of
the non-comparative nature of the study, only
descriptive statistics were performed.
2.2. Microbiological analysis
The detection, identification and susceptibility
testing of S. typhi from clinical specimens were
done at the Clinical Microbiology Laboratory of
the Department of Pathology and Laboratory Med-
icine. This Laboratory has been accredited by the
College of American Pathologists (CAP) since
2004. Briefly, the recovery of S. typhi isolates from
blood was based on the BactAlert system (Bio Mer-
ieux, Marcy-lEtoile, Lyon, France), and sub-cultur-
ing positive bottles on blood, chocolate, and Mac
Conkey agar media (Becton Dickinson Microbiology
Systems, NJ, USA). Recovery from stool specimens
was based on the direct inoculation of specimen on
selective media, XLD (Xylose-Lysine-Deoxycholate)
agar, and Selenite broth for the enrichment of Sal-
monella and Shigella. After 12–18 h, the Selenite
broth was subcultured on SS (Salmonella-Shigella)
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positive H2S reaction, were identified based on bio-
chemical sugar reactions, API E system (Bio Meri-
eux, Marcy-lEtoile, Lyon, France) and by
serotyping with specific anti-Salmonella anti-sera
(Denka Seiken Co., Coventry, UK). Isolates were
stored in Brucella-Glycerin broth storage medium
(BD). Antimicrobial susceptibility testing was done
by the disk-diffusion (Kirby-Bauer) method using
suspensions of 0.5 MacFarland from fresh bacterial
cultures on Mueller-Hinton agar (BD) according to
the guidelines of the Clinical Laboratory Standards
Institute (CLSI, 2009) [8]. E. coli ATTCC # 25,9922
was used as a quality control reference strain.
The following antimicrobial disks (BD) were used:
ampicillin (disk content 10 lg), SXT, ceftazidime
(30 lg), cefotaxime (30 lg), ciprofloxacin (5 lg),
norfloxacin (10 lg), and ceftriaxone (30 lg). In
addition, nalidixic acid disk (30 lg) was used to
screen for fluoroquinolone resistance. If an isolate
showed resistance to nalidixic acid, a note in the
report was added: ‘‘since isolate is resistant to
nalidixic acid, treatment with fluoroquinolones
might be compromised.’’ The performance and
interpretation of this procedure and results are
based on the 2009 CLSI guidelines.
2.3. Molecular analysis
All S. typhi isolates underwent Pulsed-Field Gel
Electrophoresis (PFGE) to study their genotypic
patterns. PFGE was carried out according to Pulse-
Net protocol (PulseNet International) using the
restriction enzyme XbaI (Fermentas Life Sciences,
Canada), with Salmonella Braenderup H9812 as a
reference strain. Electrophoresis was performed
using CHEF MAPPER (Bio Rad Laboratories GMBH,
Munchen, Germany). The gels were stained with
ethidium bromide (AMERCO, Ohio, USA) and photo-
graphed under UV light illumination by Gel Doc (Bio
Rad Laboratories GMBH, Munchen, Germany). The
images were analyzed with BIONUMERICS 5.1
(Applied Maths, Saint-Martens-Latem, Belgium).
2.5% tolerance and optimization criteria were
imposed for the analysis, according to Dices crite-
rion. The dendrogram was constructed with UPGMA
(Unweighted Pair Group Method using Arithmetic
Averages).
3. Results
3.1. Clinical data
A total of 120 patients with typhoid fever were
identified over the course of the study period from
various geographical locations in the country(Fig. 1). Clinical data were complete and available
for 69 patients (33 males and 36 females); the
remaining 51 patients with missing clinical data
were excluded from the clinical analysis. The mean
age of enrolled patients was 23 years (median
19 years; range 1–82 years). The majority of
patients were residents of urban areas, with 40%
residing in the capital Beirut (Figs. 2A and B). The
average number of household members was 5
(range 1–11), and the highest attained level of
education was reported as elementary for 35.7%
of patients and college degree for 28.6% of
patients. A sizable proportion of patients relied
on bottled water as the source of drinking water
at home (50.9%), followed by drinking water from
commercial providers (31.6%) and municipal water
system (17.5%). Additionally, the majority of
homes were connected to the municipal sewage
system (68%), while others were connected to cess-
pools (32%).
The clinical characteristics of patients are sum-
marized in Table 1. Only a small fraction of
patients had serious co-morbid conditions
(11.7%). Four patients (6.2%) had a previous epi-
sode of typhoid fever within the 6 months preced-
ing the current episode. In addition, 7 patients
(12.3%) reported a similar illness in the household
concurrent with their illness. The most common
presenting symptoms were fever (100%), headache
(56.5%), abdominal pain (46.4%), diarrhea (40.6%)
and vomiting (39.1%). Two patients who were sis-
ters presented with genital ulcerations.
Of the 120 patients included in the study ini-
tially, 111 were diagnosed by blood or stool cul-
ture, and 9 were diagnosed by serological testing.
Of the 69 patients included in the clinical analysis,
the diagnosis was confirmed through blood cultures
in 66 patients, serology in 2 patients, and stool cul-
ture in 1 patient in the setting of a compatible clin-
ical illness. Third generation cephalosporins were
the most commonly used agents for the treatment
of typhoid fever (n = 48; 69.5%), followed by quin-
olones (n = 20; 29.5%). The mean duration of anti-
biotic treatment was 14 ± 2.8 days (range 5–
21 days). All patients recovered from the illness
without any serious complications.
3.2. Microbiological data
Susceptibility testing of the recovered isolates
revealed resistance to ampicillin and trimetho-
prim/sulfamethoxazole in only 1 isolate, which
maintained susceptibility against third generation
cephalosporins and quinolones. All other
isolates showed uniform susceptibility to ampicil-
lin, third generation cephalosporins, quinolones
Fig. 1 Flowchart of the distribution of patients included in the study.
Fig. 2A Geographic distribution by regions of residence in Lebanon of patients with confirmed typhoid fever.
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sulfamethoxazole.
3.3. Molecular data
Molecular analysis and PFGE were completed on
the 111 isolates received from patients. The den-
drogram is shown in Fig. 3. Association with geo-
graphical area was confirmed by studies on 59
cases for which genotypic and epidemiological data
were available. The most commonly identified
cluster was cluster III. It accounted for a total of
49 isolates. The percent of isolates from various
regions belonging to cluster III is distributed as fol-
lows: 62.5% from Bekaa, 47.0% from Mount Leba-
non, 41.6% from Beirut, and 12.5% from South
Lebanon. None of the isolates from North Lebanonbelonged to cluster III. All other clusters were dis-
tributed evenly among all regions in Lebanon.
4. Discussion
Typhoid fever continues to be a problem in Leba-
non, especially during the summer months. In a
recent epidemiological study, a total of 6,148
cases of typhoid fever were reported in Lebanon
between 2000 and 2008, with an annual range from
461 to 891 cases, and with the highest incidence
occurring from June to August [9]. Similar to this
current cohort, most patients in the national study
were children and young adults between the ages
of 10 and 39 years. Except for the genital ulcers
seen in the 2 sisters [10] and the common occur-
rence of diarrhea in up to 40% of patients, the clin-
Table 1 Clinical characteristics of patients with typhoid
fever in Lebanon between October 2006 and January 2008
(N = 69).
Patient Characteristics Value N (%)
Comorbidities
Diabetes mellitus 3 (4.4)
Congestive heart failure 3 (4.4)
Immunosuppressive therapy 2 (2.9)
Signs and symptoms
Fever 69 (100)
Headache 39 (56.5)
Abdominal pain 32 (46.4)
Diarrhea 28 (40.6)
Vomiting 27 (39.1)
Constipation 8 (11.6)
Oral lesions 7 (10.1)
Hepatomegaly and/or splenomegaly 6 (8.7)
Genital lesions 2 (2.9)
Need for hospitalization 64 (92.8)
Similar illness in the household 7 (12.3)
Typhoid fever within past 6 months 4 (6.2)
Duration of fever, mean (range) 8 (2–30)
Length of hospital stay, mean (range) 6 (1–13)
Survival 69 (100)
Fig. 2B Map of Lebanon showing various geographic
regions (Courtesy of Google search: http://www.sode-
tel.net.lb/common/flash/map.swf).
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were similar to what has been previously reported
in the literature. These results showed that typhoid
fever occurred mostly in younger patients living incrowded households. This finding is consistent with
several epidemiological studies showing that low
socioeconomic status and poor living conditions
are risk factors for acquiring the infection [11].
Contaminated food and water supplies have been
frequently identified as sources of typhoid fever
outbreaks [12,13]. Since most patients in this study
population consumed bottled water, it seems that
drinking water is a less likely vehicle for the trans-
mission of the pathogen, although contaminated
bottled water has been reported from this country.
Household water used for bathing, washing, and
cooking, however, remains a possible explanation
since it is widely contaminated.
Thereisgrowingevidenceshowingthatmulti-drug
resistant S. typhi strains are increasing worldwide. A
recentanalysisof41casesoftyphoidfeverfromCambo-
diashowedmulti-drugresistanceratesof56%(against
ampicillin, trimethoprim/sulfamethoxazole, and
chloramphenicol) [14]. InanotherstudyfromCanada
[15], resistance of S. typhi isolates to nalidixic acid
reached 80% while resistance to beta-lactams
remained constant between 2002 and 2007. It should
bekept inmind,however, that resistancetonalidixic
acidpredictstreatmentfailurewithfluoroquinolones
(despite invitrosusceptibilityoftheisolatetofluoro-
quinolones). Therefore, high resistance rates of S.
typhitonalidixicacidmightprecludetheuseofquino-
lonesintheempirictreatmentoftyphoidfeverinCan-
ada. On the other hand, other studies have indicated
that while resistance to quinolones is now rampant
among S. typhi, other conventional therapeutic
optionshave regainedsusceptibility. Forexample, in
theIndiansubcontinent,susceptibilityratesof128iso-
latesofS.typhitochloramphenicol,ampicillin,andtri-
methoprimexceeded90%[16].Theresultsofthisstudy
confirm that in Lebanon, antimicrobial resistance
amongS.typhiisolatesisstillrare(Table2).Therefore,
ampicillin, cephalosporins, quinolones, or trimetho-
prim/sulfamethoxazole remain appropriate thera-
peuticchoicesinpatientswithtyphoidfeverwhohave
acquired the infection locally. Recentdata compiled
from 2000 to 2011 at one large tertiary care teaching
hospitalinBeirutsuggestthatS.typhihasremaineduni-
formlysusceptibletothirdgenerationcephalosporins
andquinolones.Susceptibilityhasrangedbetween60%
and100%forampicillinandbetween43%and100%for
trimethoprim/sulfamethoxazole[17].
Molecular analysis revealed the predominance
of one circulating genotype. However, there was
no apparent geographical predilection. This can
probably be accounted for by the high mobility of
the Lebanese population, e.g., from place of resi-
dence to place of work. It should be noted, how-
ever, that due to the fact that a systematic
Fig. 3 Dendrogram for 111 S. typhi isolates.
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Table 2 Susceptibility data of S. typhi at the American university of Beirut Medical center between 1 July 2006 and 30
June 2013.
2006–07 2007–08 2008–09 2009–10 2010–11 2011–12 2012–13
Ampicillin 93 92 100 71 84 60 100
Cefotaxime 100 100 100 100 100 100 100
Ceftazidime 100 100 100 100 100 100 100
Ciprofloxacin 100 100 100 100 100 100 100
Norfloxacin 100 100 100 100 100 100 100
Trimeth/Sulfa 93 100 100 43 84 60 100
Epidemiology, clinical manifestations 165sampling method was not followed, the isolates
included in this study might not be representative
of the country as a whole.
In conclusion, young healthy individuals living in
crowded households are at risk of acquiring typhoid
fever in Lebanon. Antimicrobial resistance among S.
typhi isolates has so far been uncommon in this
country.
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